Zobrazeno 1 - 8
of 8
pro vyhledávání: '"María Belén Tardivo"'
Autor:
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego Alvarez, Eliana Castro, Juliana Cassataro, Natalia Ceaglio, Claudio Prieto
Publikováno v:
Applied Microbiology and Biotechnology. 107:3429-3441
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed62379ce274bec391b4cd788c30bb77
https://doi.org/10.1007/s00253-023-12520-5
https://doi.org/10.1007/s00253-023-12520-5
Autor:
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio Prieto
Publikováno v:
The Protein Journal. 42:24-36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a9fe53ff3bb088268c8d2cc3945a5ca
https://doi.org/10.1007/s10930-023-10092-x
https://doi.org/10.1007/s10930-023-10092-x
Autor:
María Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, Javier Villarraza, Ernesto Garay, Antonela Fuselli, Victoria Gastaldi, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Claudio Prieto
Publikováno v:
Applied microbiology and biotechnology. 106(23)
Serology assays are essential tools to mitigate the effect of COVID-19, help to identify previous SARS-CoV-2 infections or vaccination, and provide data for surveillance and epidemiologic studies. In this study, we report the production and purificat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc61db890a3c7d20752369fd6ae9c28c
https://pubmed.ncbi.nlm.nih.gov/36329132
https://pubmed.ncbi.nlm.nih.gov/36329132
Autor:
Alejandro Macagno, Luciano Cattaneo, Diego Fontana, Natalia Ceaglio, Sebastián Antuña, Pablo Uriel Díaz, Hugo Hector Ortega, María Belén Tardivo, Gabriel A. Bó, María Celeste Rodríguez, Claudio Prieto, A. Tribulo, Carlos Javier Villarraza, Pablo Mussio
Publikováno v:
Theriogenology. 172
Equine chorionic gonadotropin (eCG) is a heterodimeric glycoprotein hormone produced by pregnant mares that has been used to improve reproductive performance in different domestic species. Several strategies to produce the hormone in a recombinant wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0426cd457bb46e2a65cd9dc074ef4929
https://pubmed.ncbi.nlm.nih.gov/34082223
https://pubmed.ncbi.nlm.nih.gov/34082223
Autor:
María Celeste, Rodríguez, Natalia, Ceaglio, Sebastián, Antuña, María Belén, Tardivo, Marina, Etcheverrigaray, Claudio, Prieto
Publikováno v:
Advances in experimental medicine and biology. 1148
Since ERT for several LSDs treatment has emerged at the beginning of the 1980s with Orphan Drug approval, patients' expectancy and life quality have been improved. Most LSDs treatment are based on the replaced of mutated or deficient protein with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e523b705a3563eba56f58792cb59513a
https://pubmed.ncbi.nlm.nih.gov/31482493
https://pubmed.ncbi.nlm.nih.gov/31482493
Autor:
Natalia Ceaglio, Sebastián Antuña, María Belén Tardivo, Marina Etcheverrigaray, María Celeste Rodríguez, Claudio Prieto
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9789811377082
Since ERT for several LSDs treatment has emerged at the beginning of the 1980s with Orphan Drug approval, patients' expectancy and life quality have been improved. Most LSDs treatment are based on the replaced of mutated or deficient protein with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6087edc5194cfec9212c0f02360fce5
https://doi.org/10.1007/978-981-13-7709-9_2
https://doi.org/10.1007/978-981-13-7709-9_2
Autor:
Natalia Ceaglio, María Celeste Rodríguez, Claudio Prieto, Marina Etcheverrigaray, Sebastián Antuña, María Belén Tardivo
Publikováno v:
Biotechnology progress. 33(5)
Fabry disease is an X-linked recessive disorder caused by a deficiency in lysosomal α-Galactosidase A. Currently, two enzyme replacement therapies (ERT) are available. However, access to orphan drugs continues to be limited by their high price. Sele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebc14f1f03b57336eb065601d96bde73
https://pubmed.ncbi.nlm.nih.gov/28840666
https://pubmed.ncbi.nlm.nih.gov/28840666
Autor:
Agustina Gugliotta, Dianela Cravero, Natalia Ceaglio, Ricardo Kratje, María Belén Tardivo, Marina Etcheverrigaray, Marcos Oggero
Improving in vivo half-life and in vitro stability of protein-based therapeutics is a current challenge for the biopharmaceutical industry. In particular, recombinant human interferon alpha-2b (rhIFN-α2b), which belongs to a group of cytokines exten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a706aafeeb47bea70fbddc33b52cdb51
https://www.sciencedirect.com/science/article/pii/S0168165616300190
https://www.sciencedirect.com/science/article/pii/S0168165616300190